MYC and cancer: Such inhibitors hold the potential to address diseases characterized by aberrant c‐Myc activity, including certain autoimmune disorders, while also enhancing the efficacy of existing cancer treatments such as chemotherapy and radiation.15, 16, 17, 18 Ultimately, the development of innovative c‐Myc inhibitors holds promise for more effective treatments across a range of diseases.